首页> 外文期刊>The Lancet >Severe reactions to filarial chemotherapy and release of Wolbachia endosymbionts into blood.
【24h】

Severe reactions to filarial chemotherapy and release of Wolbachia endosymbionts into blood.

机译:丝状化学疗法反应严重,Wolbachia内共生菌释放到血液中。

获取原文
获取原文并翻译 | 示例
           

摘要

Wolbachia bacteria seem to have evolved as essential endosymbionts of their filarial nematode hosts. Studies in mice have suggested that these bacteria are associated with systemic inflammatory reactions to filarial chemotherapy. We took blood samples from 15 Indonesian patients before and after treatment with diethylcarbamazine for Brugia malayi infection, and recorded the severity of any post-treatment inflammatory reactions. Blood from all three patients with severe adverse reactions and from one of six with moderate reactions was positive for Wolbachia DNA 4-48 h after diethylcarbamazine treatment. We suggest that these severe inflammatory reactions are associated with the release of endosymbionts into the blood after treatment for filariasis.
机译:Wolbachia细菌似乎已经进化为其丝线虫宿主的内共生菌。小鼠研究表明,这些细菌与丝状化学疗法的全身炎症反应有关。我们从二乙基卡巴嗪治疗马来氏布鲁氏菌感染之前和之后抽取了15名印度尼西亚患者的血液样本,并记录了治疗后任何炎症反应的严重程度。二乙基卡巴嗪治疗后4-48 h,来自所有三例严重不良反应的患者和六例中度反应的患者之一的Wolbachia DNA均为阳性。我们建议这些严重的炎症反应与丝虫病治疗后内共生菌释放到血液中有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号